Topiramate (TPA) is a broad-spectrum antiepileptic drug. Owing to its diverse and multifaceted mechanisms of action, its therapeutic indications have expanded beyond epilepsy to include bipolar disorder, obesity, eating disorders, migraine prophylaxis, post-traumatic stress disorder (PTSD), and certain malignancies.

AccuSift provides high-performance competitive antibody pairs for topiramate detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 0.5 μg/mL